The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
Crossref DOI link: https://doi.org/10.1186/s13104-016-2243-8
Published Online: 2016-09-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wicks, Paul https://orcid.org/0000-0002-2293-9284
Rasouliyan, Lawrence
Katic, Bo
Nafees, Beenish
Flood, Emuella
Sasané, Rahul
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation